Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.

Source:http://linkedlifedata.com/resource/pubmed/id/8920892

J. Exp. Med. 1996 Nov 1 184 5 2037-41

Download in:

View as

General Info

PMID
8920892